Abstract # 2125 Concurrent Chemoradiotherapy with Full-dose Gemcitabine for Unresectable Pancreatic Cancer

Presenter: Nakamura, Satoaki

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

Treatment of concurrent full-dose gemcitabine and radiotherapy is one of the promising approaches for locally advanced pancreatic cancer. This study evaluated the effectiveness and feasibility of concurrent chemoradiotherapy with a full-dose of gemcitabine for unresectable pancreatic cancer.